Clinical Trials · NCT01016210

The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
The Baruch Padeh Medical Center, Poriya
Enrollment
60
Start date
Feb 2010
Locations
1 site, Israel
Primary endpoint
Pregnancy rate
View Gonadorelin compound reference